Pharmaxis Ltd reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported revenue was AUD 8.08 million compared to AUD 5.89 million a year ago. Net income was AUD 0.943 million compared to net loss of AUD 3.03 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | 0.00% | -5.00% | -5.00% |
04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.00% | 15.04M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Pharmaxis Ltd Reports Earnings Results for the First Quarter Ended September 30, 2022